Stock 4527 ROHTO PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Rohto Pharmaceutical Co.,Ltd.

Equities

4527

JP3982400008

Pharmaceuticals

Delayed Japan Exchange
Other stock markets
 03:30:00 01/05/2024 BST 		5-day change 1st Jan Change
3,085 JPY +0.06% Intraday chart for Rohto Pharmaceutical Co.,Ltd. +3.42% +8.51%
04-04 Rohto Pharmaceutical Eyes MGO on Singapore's Eu Yan Sang International for 88 Billion Yen MT
04-04 Rohto Pharmaceutical, Mitsui & Co. to Acquire Singapore-Based Eu Yan Sang -- Update DJ

Business Summary

ROHTO PHARMACEUTICAL CO., LTD. is a Japan-based company principally engaged in the health and beauty care area. The Company primarily provides eye care-related products, including eye drops and eye lotions; skin care-related products, including dermatological preparations, lip balms, sunscreens and functional cosmetics; oral medication and food-related products, including digestive medicines, Chinese herbal medicines and supplements, as well as extracorporeal test drugs and other products. The Company operates its business in domestic market and overseas markets, including Europe, Asia and America.

Number of employees: 7,176

Sales per Business

JPY in Million2022Weight2023Weight Delta
Skin Care
65.6 %
124,055 62.1 % 156,657 65.6 % +26.28%
Eye Care
20.2 %
43,102 21.6 % 48,180 20.2 % +11.78%
Internal Medicine
11.1 %
25,604 12.8 % 26,588 11.1 % +3.84%
Other
3.0 %
6,884 3.4 % 7,237 3.0 % +5.13%

Sales per region

JPY in Million2022Weight2023Weight Delta
Japan
57.3 %
121,417 60.8 % 136,668 57.3 % +12.56%
Asia
29.7 %
55,988 28.0 % 70,773 29.7 % +26.41%
America
7.0 %
10,037 5.0 % 16,655 7.0 % +65.94%
Europe
5.1 %
10,297 5.2 % 12,231 5.1 % +18.78%
Others
1.0 %
1,906 1.0 % 2,337 1.0 % +22.61%

Managers

Managers TitleAgeSince
Masashi Sugimoto PSD
 President 62 31/12/18
Kunio Yamada CHM
 Chairman 68 01/04/80
Masamitsu Inoue DFI
 Director of Finance/CFO - -
Atsushi Hiyama BRD
 Director/Board Member 58 31/03/20
Chiharu Takakura BRD
 Director/Board Member 64 31/03/20
Masaya Saito BRD
 Director/Board Member 60 31/03/86
Shinichi Kunisaki BRD
 Director/Board Member 68 31/12/06
Masako Chikaraishi PRN
 Corporate Officer/Principal 65 31/03/82
Hidetoshi Segi PRN
 Corporate Officer/Principal 61 31/05/97
Hideto Kamimura AUD
 Comptroller/Controller/Auditor 65 31/03/82

Members of the board

Members of the board TitleAgeSince
Kunio Yamada CHM
 Chairman 68 01/04/80
Yasuhiro Yamada PRN
 Corporate Officer/Principal 85 28/02/62
Masanori Kimura AUD
 Comptroller/Controller/Auditor 66 31/03/82
Shinichi Kunisaki BRD
 Director/Board Member 68 31/12/06
Hideto Kamimura AUD
 Comptroller/Controller/Auditor 65 31/03/82
Akie Iriyama BRD
 Director/Board Member 51 31/05/19
Masako Chikaraishi PRN
 Corporate Officer/Principal 65 31/03/82
Haruka Mera BRD
 Director/Board Member 36 25/06/20
Chiharu Takakura BRD
 Director/Board Member 64 31/03/20
Atsushi Hiyama BRD
 Director/Board Member 58 31/03/20

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 236,178,310 199,736,821 ( 84.57 %) 8,039,461 ( 3.404 %) 84.57 %

Shareholders

NameEquities%Valuation
MFS International (UK) Ltd.
5.198 %
12,277,300 5.198 % 241 M ¥
MITSUBISHI UFJ FINANCIAL GROUP, INC
4.263 %
10,069,000 4.263 % 197 M ¥
SPARX Asset Management Co., Ltd.
3.471 %
8,198,198 3.471 % 161 M ¥
ROHTO PHARMACEUTICAL CO.,LTD.
3.404 %
8,039,400 3.404 % 158 M ¥
Kiyoko Yamada
2.514 %
5,938,000 2.514 % 116 M ¥
Yamada Family
2.378 %
5,616,000 2.378 % 110 M ¥
Sansho Kosan KK
2.158 %
5,096,000 2.158 % 100 M ¥
Nippon Life Insurance Co.
1.794 %
4,238,000 1.794 % 83 M ¥
Kunio Yamada
1.655 %
3,908,000 1.655 % 77 M ¥
FIL Investments (Japan) Ltd.
0.8496 %
2,006,469 0.8496 % 39 M ¥

Holdings

NameEquities%Valuation
ROHTO PHARMACEUTICAL CO.,LTD.
3.40%
 8,039,400 3.40% 157,606,166 $
ASICS CORPORATION
0.21%
 408,000 0.21% 19,682,234 $
MITSUBISHI UFJ FINANCIAL GROUP, INC
0.01%
 1,380,000 0.01% 14,197,095 $
OHKI HEALTHCARE HOLDINGS CO.,LTD.
12.50%
 1,759,000 12.50% 11,506,235 $
MATSUKIYOCOCOKARA & CO.
0.16%
 665,700 0.16% 10,730,285 $
YAKULT HONSHA CO.,LTD.
0.10%
 346,600 0.10% 7,142,920 $
MORISHITA JINTAN CO., LTD.
8.55%
 355,000 8.55% 5,791,371 $
EUGLENA CO., LTD.
0.79%
 1,069,500 0.79% 4,282,385 $
SUMITOMO MITSUI FINANCIAL GROUP, INC.
0.01%
 71,100 0.01% 4,185,338 $
MEIJI HOLDINGS CO LTD
0.06%
 180,400 0.06% 4,036,039 $

Company contact information

Rohto Pharmaceutical Co., Ltd.

1-8-1 Tatsumi-nishi Ikuno-Ku

544-8666, Osaka

+

http://www.rohto.co.jp
address Rohto Pharmaceutical Co.,Ltd.(4527)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Rohto Pharmaceutical Co.,Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
3,083 JPY
Average target price
3,892 JPY
Spread / Average Target
+26.26%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ROHTO PHARMACEUTICAL CO.,LTD. Stock Rohto Pharmaceutical Co.,Ltd.
+8.51% 4.42B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+34.00% 664B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.29% 567B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.75% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.53% 330B
ABBVIE INC. Stock AbbVie Inc.
+4.95% 286B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.79% 234B
NOVARTIS AG Stock Novartis AG
+4.93% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-9.78% 196B
AMGEN INC. Stock Amgen Inc.
-4.89% 148B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4527 Stock
  4. Company Rohto Pharmaceutical Co.,Ltd.